POET Technologies: When a $830 Million War Chest Isn't Enough to Calm Nerves
Published on 07/27/2026 at 08:12 | Redaktion boerse-global.de
The math is brutal but instructive. POET Technologies shares have shed roughly two-thirds of their value since touching a 52-week high of €18.84 in mid-May, closing Friday at €6.09 — a 67.68% descent that has wiped out the premium the market once assigned to this photonics play. The single-day drop of 8.83% on Friday was merely the latest installment in a 30-day slide of 26.27%, pushing the stock 11.04% below its 200-day moving average of €6.85 and a staggering 36.53% beneath the 50-day average of €9.60.
This is not a garden-variety sector correction. The relative strength index at 36.2 is flirting with oversold territory, but technical indicators offer cold comfort when the underlying problem is not about price — it's about trust.
The Marvell Episode That Won't Fade
The trouble traces back to April, when Marvell Semiconductor, fresh from acquiring Celestial AI, canceled all outstanding orders with POET. The stated reason: an alleged breach of confidentiality involving shipping and order details. One incident, but its aftershocks have been seismic.
By late June and into July, multiple shareholder class-action lawsuits landed. The complaints allege that management failed to disclose material risks around confidentiality protocols and the company's tax status. The optics could hardly be worse for a company trying to convince hyperscalers — the most security-conscious customers on the planet — that it can be a reliable Tier-1 supplier.
Should investors sell immediately? Or is it worth buying POET Technologies?
CEO Suresh Venkatesan remains at the helm to steer the commercialization phase, but CFO Thomas Mika announced his retirement for later this year. The search for a replacement comes at precisely the moment when financial precision matters most. A leadership vacuum in the finance department, coinciding with a legal assault and a customer defection, explains why the market is pricing in risk rather than potential.
Ambition Meets a Reality Check
On the production front, the narrative remains ambitious. POET plans to begin its manufacturing ramp for optical engines in the second half of 2026, targeting a tenfold capacity increase to one million units per month by the end of 2027. The company has earmarked roughly $50 million for new fabrication equipment in the coming months.
That spending is backed by a formidable cash cushion. Over the past twelve months, POET has raised approximately $830 million in equity capital, giving it the financial runway to execute its plan. The current market capitalization of €417.38 million, however, suggests investors are deeply skeptical that the plan will materialize on schedule — or at all.
The dilution from those equity raises and associated warrants caps any near-term upside, even as the company's year-to-date return remains positive at 6.10% and the twelve-month gain still stands at 20.36%. Those figures mask the severity of the recent sell-off, which has been concentrated and punishing.
The Two Pillars That Haven't Held
POET's fundamental case rests on two promises: the Lumilens supply commitment and the conversion of more than ten active customer discussions into recurring revenue. Both sound promising. Neither has been validated in verifiable financial results.
The real test begins when POET's manufacturing partners in Malaysia actually ship volume and those units translate into recognized revenue. Until then, the company occupies an uncomfortable gap — a €417 million market capitalization attached to an industrial ambition that demands multiples of that valuation to be credible.
POET Technologies at a turning point? This analysis reveals what investors need to know now.
The annualized 30-day volatility of 93.41% tells its own story. This is a stock that can move violently in either direction, and the bias has been decisively negative. A technical bounce from oversold levels is possible, but no indicator can substitute for operational confirmation.
What August Will Reveal
The coming weeks and the second-half earnings report will determine whether the production timeline gains traction or remains a PowerPoint promise. For now, POET Technologies is caught between a technological breakthrough in silicon photonics and a governance crisis that has spooked the very customers and investors it needs most.
The path back to credibility runs through the courtroom and the boardroom before it can return to the lab. Until the lawsuits are resolved, the CFO transition is executed cleanly, and those customer conversations convert into non-cancelable orders, the stock will remain what it has become: a barometer of how quickly the market swaps patience for skepticism when promises must meet production.
Ad
POET Technologies Stock: New Analysis - 27 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
